Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Louis J. Vollmer
BRD | Director/Board Member | - | - |
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Elaine Jones
BRD | Director/Board Member | 69 | - |
Calvin Johnson
BRD | Director/Board Member | 57 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Henrietta Ukwu
BRD | Director/Board Member | 64 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 450 000 | 0 | 0 | 80,00 % |
Acción B | 1 | 13 800 000 | 13 800 000 ( 100,00 %) | 0 |
Información de la empresa
![Dirección Ibere Pharmaceuticals(IBER)](https://cdn.zonebourse.com/static/address/121553411.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+124,29 % | 6935,5 M | |
+98,02 % | 1249,71 M | |
+2,95 % | 990 M | |
+23,30 % | 806 M | |
+2,11 % | 666 M | |
-.--% | 600 M | |
-0,36 % | 604 M | |
+11,11 % | 540 M | |
-.--% | 500 M |